β-adrenergic blockade during severe ischemia

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 16, Issue 6, 2002, Pages 670-678

  Coetzee, Andre ^a   Coetzee, Gert ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

Acebutolol; Myocardial ischemia; adrenergic blockade

Indexed keywords

ACEBUTOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; LACTIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY OBSTRUCTION; DISEASE SEVERITY; DOPPLER FLOWMETRY; DRUG EFFECT; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE BLOOD FLOW; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HEART MUSCLE OXYGEN CONSUMPTION; NONHUMAN; PRIORITY JOURNAL; SWINE;

EID: 0036955760     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/jcan.2002.128420     Document Type: Article

References (50)

1. Mueller H, Ayres SM, Religa A, Evans RG: Propranolol in the treatment of acute myocardial infarction: Effect on myocardial oxygenation and hemodynamics. Circulation 49:1078-1087, 1974
2. Jackson G, Atkinson L, Oram S: Improvement of myocardial metabolism in coronary arterial disease by beta-blockade. Br Heart J 39:829-833, 1977
3. Braunwald E, Muller JE, Kloner RA, Maroko PR: Role of beta-adrenergic blockade in the therapy of patients with myocardial infarction. Am J Med 74:113-123, 1983
4. Stone JG, Foëx P, Sear JW, et al: Myocardial ischemia in the untreated hypertensive patient: Effect of a single small oral dose of a beta-adrenergic blocking agent. Anesthesiology 68:495-500, 1988
5. Pasternack PF, Grossi EA, Baumann FG, et al: Beta-blockade to decrease silent myocardial ischemia during peripheral vascular surgery. Am J Surg 158:113-116, 1989
6. Yeager RA, Moneta GL, Edwards JM, et al: Reducing perioperative myocardial infarction following vascular surgery. Arch Surg 130:869-873, 1995
7. Urban MK, Markowitz SM, Gordon MA, et al: Postoperative prophylactic administration of beta-adrenergic blockers in patients at risk for myocardial ischemia. Anesth Analg 90:1257-1261, 2000
8. Slogoff S, Keats AS: Does perioperative myocardial ischemia lead to postoperative myocardial infarction? Anesthesiology 62:107-114, 1985
9. Wallace A, Layug B, Tateo I, et al: Prophylactic atenolol reduces postoperative myocardial ischemia. Anesthesiology 88:7-17, 1998
10. Mangano DT, Layug B, Wallace A, Tateo I: Effects of atenolol on mortality and cardiovascular morbidity after non-cardiac surgery. N Engl J Med 335:1713-1720, 1996
11. Poldermans D, Boersma E, Bax J, et al: The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. N Engl J Med 341:1789-1794, 2001
12. Jones KG, Powell JT: Slowing the heart saves lives: Advantages of perioperative beta-blockade. Br J Surg 87:689-690, 2000
13. Warltier DC: Beta-adrenergic blocking drugs: Incredibly useful, incredibly underutilized. Anesthesiology 88:2-4, 1998
14. Howell SJ, Sear JW, Foëx P: Perioperative beta-blockade: A useful treatment that should be greeted with cautious enthusiasm. Br J Anaesth 86:161-164, 2001
15. Leone BJ, Lehot JJ, Francis M, et al: Beta-blockade reverses regional dysfunction in ischemic myocardium. Anesth Analg 66:607-614, 1987
16. Nanki M, Itoh K, Matsubara T, et al: Evaluation of the effects of metoprolol on energy metabolism in the ischemic myocardium in relation to regional myocardial blood flow. Cardiovas Res 21:660-667, 1987
17. Matsuzaki M, Patritti J, Tajima T, et al: Effects of beta-blocakde on regional myocardial flow and function during exercise. Am J Physiol 247:H52-H60, 1984
18. Grover GJ, Weiss HR, Kostis JB, et al: Beta-adrenergic stimulation and blockade during myocardial ischemia in dogs: Effects on cardiac oxygen supply and consumption. Br J Pharmacol 142:103-113, 1987
19. Grith BD, Heusch G, Seitelberg R, et al: Mechanism of beneficial effects of beta-adrenergic blockade on exercised-reduced myocardial ischemia in conscious dogs. Circ Res 60:738-746, 1987
20. Vinten-Johansen J, Johnston WE, Crystal GJ, et al: Validation of local venous sampling within the at-risk left anterior descending artery vascular bed in the canine left ventricle. Cardiovasc Res 21:646-651, 1987
21. Coetzee A, Fourie P: Postsystolic shortening as an index of regional myocardial ischemia in an experimental model. J Cardiothorac Vasc Anesth 5:546-550, 1991
22. Brown MA, Norris RM, Takayama, White H: Postsystolic shortening: A marker of potential early recovery of acutely ischemic myocardium in the dog. Cardiovasc Res 21:703-716, 1987
23. Kaseda S, Tomoike H, Ogata I, Nakamura M: End-systolic pressure-length relation during changes in regional contractile state. Am J Physiol 247:H768-H774, 1984
24. Forrester JS, Tyberg JV, Wyatt HL, et al: Pressure-length loop: A new method for simultaneous measurement of segmental and total cardiac function. J Appl Physiol 37:771-775, 1974
25. 2: A reliable index of the severity of myocardial ischemic injury. Am J Physiol 237:H253-H259, 1979
26. Hillis LD, Khuri SF, Braunwald E, et al: Assessment of the efficacy of interventions to limit injury by direct measurement of intramural carbon dioxide tension after coronary artery occlusion in the dog. J Clin Invest 63:99-107, 1979
27. Gould K, Lipscomb K, Calvert C: Compensatory changes of the coronary vascular bed during progressive coronary constriction. Circulation 51:1085-1094, 1975
28. Kumada T, Karliner JS, Pouleur H, et al: Effects of coronary occlusion on early ventricular diastolic events in conscious dogs. Am J Physiol 237:H542-H549, 1979
29. Takayama M, Norris RM, Brown MA, et al: Postsystolic shortening of acutely ischemic canine myocardium predicts early and late recovery of function after coronary reperfusion. Circulation 78:994-1007, 1988
30. Wyatt HL, Forrester JS, Tyberg JV, et al: Effect of graded reductions in regional coronary perfusion on regional and total cardiac function. Am J Cardiol 36:185-192, 1975
31. Guth BD, Wisneski JA, Neese RA, et al: Myocardial lactate release during ischemia in swine: Relation to regional blood flow. Circulation 81:1948-1958, 1990
32. Sarnoff SJ, Braunwald E, Welch GH, et al: Hemodynamic determinants of oxygen consumption of the heart with special reference to the time-tension index. Am J Physioi 192:148-156, 1958
33. Eckenhof JE, Hafkenschiel JH, Landmesser CM, et al: Cardiac oxygen metabolism and control of the coronary circulation. Am J Physiol 149:634-649, 1947
34. Kirk ES, Sonnenblick EH: Newer concepts in the pathophysiology of ischemic ischernic heart disease. Am Heart J 103:756-767, 1982
35. Laver M: Myocardial ischemia: Dilemma between information available and information demand. Br Heart J 50:222-230, 1983
36. Rohde E: Uber den einfluss der mechanischen dedinungen af die tatigkeit und den sauerstoffverbrauch des warrnbluterherzens. Arch Exp Pathol Pharmakol 68:401-434, 1912
37. Sonnenblick EH, Ross J, Braunwald E: Oxygen consumption of the heart: Newer concepts of its multifactorial determination. Am J Cardiol 22:328-326, 1968
38. Braunwald E: Control of myocardial oxygen consumption: Physiologic and clinical considerations. Am J Cardiol 27:416-432, 1971
39. Maxwell GM, Castillo CA, White DH, et al: Induced tachycardia: Its effect upon the coronary hemodynamics, myocardial metabolism and cardiac efficiency in the intact dog. J Clin Invest 37:1413-1418, 1958
40. Coetzee A, Holland D, Foëx P, et al: Myocardial ischemia ischernia during tachycardia - Not due to an increase in myocardial oxygen demand. S Afr J Med 67:496-499, 1985
41. Schwid H, Buffington C, Strum DP: Computer simulation of the hemodynamic determinants of myocardial oxygen supply and demand. J Cardiothorac Vasc Anesth 4:5-18, 1990
42. Becker LC, Fortuin NJ, Pitt B: Effect of ischemia and antianginal drugs on the distribution of radioactive microspheres in the canine left ventricle. Circ Res 28:263-269, 1971
43. Vatner SF, Baig H, Manders WT, et al: Effects of propranolol on regional myocardial function, electrograms and blood flow in conscious dogs with myocardial ischemia. J Clin Invest 60:353-360, 1977
44. Frishman WH: Multifactorial actions of beta-adrenergic blocking drugs in ischemic heart disease: Current concepts. Circulation 67:1-11-1-18, 1983 (suppl 1)
45. Downey JM, Kirk ES: Distribution of the coronary blood flow across the canine heart during systole. Circ Res 34:251-257, 1974
46. Backe RJ, Cobb FR: Effect of maximal coronary vasodilation on transmural myocardial perfusion during tachycardia in the awake dog. Circ, Res 41:648-653,1977
47. Ball RM, Bache RJ: Distribution of myocardial blood flow in the exercising dog with restricted coronary artery inflow. Circ Res 38:60-66, 1976
48. Hodgson J, Cohen MD, Szentpetezy S, et al: Effect of regional alpha- and beta-blockade on resting and hyperemic coronary blood flow in conscious unstressed humans. Circulation 79:797-809, 1989
49. Berdouaux A, Guidicelli JF: Intrinsic sympathomimetic activity and coronary blood flow. Br J Clin Pharmacol 13:175s-180s, 1982
50. Meyer DJ, Lawson NW: Adrenergic inhibitors. In Foex P, Harrison GG, Opie LH (eds): Cardiovascular Drugs in the Perioperative Period. Philadelphia, PA, Lippincott-Raven, 1999, pp 83-93